MedTrace Logo

Anti-aging and Anti-oxidant Efficacy Evaluation of the MelaGene

NCT05191056 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2022-03-31

No results posted yet for this study

Summary

The primary purpose of the present study is to evaluate the effects of MelaGene on anti-aging and anti-oxidant.

Conditions

  • Aging
  • Antioxidative Stress

Interventions

DIETARY_SUPPLEMENT

Placebo drink

consume 1 bottle per day for 8 weeks

DIETARY_SUPPLEMENT

MelaGene drink

consume 1 bottle per day for 8 weeks

Sponsors & Collaborators

  • TCI Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Bo han Wu, Ph.D · Pingtung University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-15
Primary Completion
2022-01-10
Completion
2022-02-28

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05191056 on ClinicalTrials.gov